![](https://eurohealthleaders.com/wp-content/uploads/2023/10/Sandoz-Novartis-Unit-Begins-Trading-at-24-CHF-After-Spinoff.jpg)
Sandoz, Novartis Unit, Begins Trading at 24 CHF After Spinoff
Novartis has successfully completed the spinoff of its generics and biosimilars business, Sandoz. The shares of Sandoz began trading at
Novartis has successfully completed the spinoff of its generics and biosimilars business, Sandoz. The shares of Sandoz began trading at
Structure Therapeutics saw a significant surge in its stock price, rising over 30%, following positive results from an early-stage trial
World Heart Day is an annual global observance on September 29 dedicated to raising awareness about the critical importance of
A study conducted by the National Institute for Health and Care Research (NIHR) has found that there is no clear
A recent study has raised concerns about Merck’s antiviral Covid pill, molnupiravir, suggesting that it can cause mutations in the
A Florida nurse practitioner, Elizabeth Hernandez, has been convicted by a federal jury in Miami for her role in a
Elon Musk’s neurotech startup, Neuralink, is set to begin recruiting patients for its first-in-human clinical trial known as the PRIME
More than 60,000 healthcare workers have voted to authorize a strike against Kaiser Permanente if an agreement is not reached
The Centers for Disease Control and Prevention (CDC) has recommended updated single-strain COVID-19 vaccines from Pfizer and Moderna for all
The Food and Drug Administration (FDA) in the United States has granted approval for updated COVID-19 vaccines from Pfizer and
Euro Health Leaders stands out as the premier destination for anyone seeking a comprehensive and insightful view of the dynamic healthcare landscape in Europe.